Dermata Therapeutics Inc.

0.02
-0.01 (-28.32%)
At close: Jan 24, 2025, 3:35 PM
0.02
0.00%
After-hours Jan 24, 2025, 03:35 PM EST

Dermata Therapeutics Statistics

Share Statistics

Dermata Therapeutics has 135.67M shares outstanding. The number of shares has increased by -11.93% in one year.

Shares Outstanding 135.67M
Shares Change (YoY) n/a
Shares Change (QoQ) 7.67%
Owned by Institutions (%) n/a
Shares Floating 136.62M
Failed to Deliver (FTD) Shares -
FTD / Avg. Volume -%

Short Selling Information

The latest short interest is 0, so 0% of the outstanding shares have been sold short.

Short Interest 0
Short % of Shares Out 0%
Short % of Float 0%
Short Ratio (days to cover) 0

Valuation Ratios

The PE ratio is -0.23 and the forward PE ratio is null.

PE Ratio -0.23
Forward PE null
PS Ratio 0
Forward PS null
PB Ratio 0.28
P/FCF Ratio -0.28
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Dermata Therapeutics Inc..

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 4.91, with a Debt / Equity ratio of 0.

Current Ratio 4.91
Quick Ratio 4.91
Debt / Equity 0
Total Debt / Capitalization 0
Cash Flow / Debt 0
Interest Coverage 0

Financial Efficiency

Return on equity (ROE) is -1.23% and return on capital (ROIC) is -126.54%.

Return on Equity (ROE) -1.23%
Return on Assets (ROA) -0.98%
Return on Capital (ROIC) -126.54%
Revenue Per Employee 0
Profits Per Employee -974.34K
Employee Count 8
Asset Turnover 0
Inventory Turnover 0

Taxes

Income Tax 0
Effective Tax Rate 0

Stock Price Statistics

The stock price has increased by null% in the last 52 weeks. The beta is 0.79, so Dermata Therapeutics 's price volatility has been higher than the market average.

Beta 0.79
52-Week Price Change null%
50-Day Moving Average 0.01
200-Day Moving Average 0.02
Relative Strength Index (RSI) 64.14
Average Volume (20 Days) -

Income Statement

Revenue n/a
Gross Profit 0
Operating Income -8.04M
Net Income -7.79M
EBITDA 247.22K
EBIT n/a
Earnings Per Share (EPS) -40.18
Full Income Statement

Balance Sheet

The company has 7.44M in cash and 0 in debt, giving a net cash position of 7.44M.

Cash & Cash Equivalents 7.44M
Total Debt 0
Net Cash 7.44M
Retained Earnings -53.39M
Total Assets 6.69M
Working Capital 4.74M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -6.41M and capital expenditures 0, giving a free cash flow of -6.41M.

Operating Cash Flow -6.41M
Capital Expenditures 0
Free Cash Flow -6.41M
FCF Per Share -33.04
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

DRMAW does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Payout Ratio n/a
Earnings Yield n/a
FCF Yield n/a
Dividend Details

Analyst Forecast

Currently there are no analyst rating for DRMAW.

Price Target n/a
Price Target Difference n/a
Analyst Consensus n/a
Analyst Count n/a
Stock Forecasts

Scores

Altman Z-Score -17.09
Piotroski F-Score 2